Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”
出版年份 2014 全文链接
标题
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”
作者
关键词
-
出版物
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 14, Issue 5, Pages 994-1002
出版商
Wiley
发表日期
2014-04-15
DOI
10.1111/ajt.12714
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
- (2013) R. J. Fontana et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection
- (2013) Edward J. Gane et al. GASTROENTEROLOGY
- 1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN (RBV)-FREE REGIMEN OF DACLATASVIR (DCV), ASUNAPREVIR (ASV), AND BMS-791325 IN TREATMENT-NAIVE, HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS
- (2013) G.T. Everson et al. JOURNAL OF HEPATOLOGY
- 43 LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA
- (2013) W.R. Kim et al. JOURNAL OF HEPATOLOGY
- 23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUP
- (2013) E.C. Verna et al. JOURNAL OF HEPATOLOGY
- 653 IMPACT OF HIGHLY EFFECTIVE ANTIVIRAL THERAPY ON THE BURDEN OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C CIRRHOSIS
- (2013) W.R. Kim et al. JOURNAL OF HEPATOLOGY
- 3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
- (2013) K.V. Kowdley et al. JOURNAL OF HEPATOLOGY
- 1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)
- (2013) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
- (2013) Audrey Coilly et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
- (2013) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation
- (2012) Fredric D. Gordon et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- 202 USE OF TELAPREVIR PLUS PEG INTERFERON/RIBAVIRIN FOR NULL RESPONDERS POST OLT WITH ADVANCED FIBROSIS/CHOLESTATIC HEPATITIS C
- (2012) P. Kwo et al. JOURNAL OF HEPATOLOGY
- Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
- (2012) Yvon Calmus et al. JOURNAL OF HEPATOLOGY
- 1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS
- (2012) F. Poordad et al. JOURNAL OF HEPATOLOGY
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
- (2012) M.-H. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: A systematic review and meta-analysis
- (2012) Rania Rabie et al. LIVER TRANSPLANTATION
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- 1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS
- (2011) A.M. Di Bisceglie et al. JOURNAL OF HEPATOLOGY
- PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus
- (2011) Natalie Bzowej et al. LIVER TRANSPLANTATION
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆
- (2010) David B. Rein et al. DIGESTIVE AND LIVER DISEASE
- Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
- (2010) Takasuke Fukuhara et al. GASTROENTEROLOGY
- Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
- (2010) Yun-Fan Liaw et al. HEPATOLOGY
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
- (2010) Michael R. Charlton et al. HEPATOLOGY
- The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study
- (2009) Roberto J. Firpi et al. DIGESTIVE DISEASES AND SCIENCES
- Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: Impact of donor age and baseline cirrhosis
- (2009) Marina Berenguer et al. LIVER TRANSPLANTATION
- Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation
- (2009) Matteo Cescon et al. LIVER TRANSPLANTATION
- Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
- (2008) M. Berenguer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection
- (2008) B. J. Veldt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection
- (2008) T. Reiberger et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started